SPACEPHARMA LIMITED
D48/100Summary
SPACEPHARMA LIMITED is an active private limited company (company number 12818608) incorporated on 17 August 2020, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£35k and cash of £855, with 2 employees on average. Net assets were unchanged on the prior period. Across the last 3 periods on record the net-asset trend is volatile.
By net assets it sits in the bottom quarter of 76 comparable companies in London (median £100, upper quartile £88k).
Key dates
- Incorporated
- 17 August 20206 yrs ago
- Next accounts due
- 30 September 2027in 343 days
- Confirmation statement due
- 31 August 2027in 313 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 51220
- Space transport
- SIC 61300
- Satellite telecommunications activities
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£35k | £855 | £201 | — | — | — | 2 |
| 31 December 2024 | −£35k | £929 | £1 | — | — | — | 2 |
| 31 December 2023 | −£33k | £0 | £1 | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-35,169 at 2025-12-31 |
| +5 | Multi-year filing history3 periods on record |
| +8 | EstablishedIncorporated 2020-08-17 (6 years) |
| 48 | Score, grade D |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
Ownership and control
- Yossef Eyal Yamin
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Next accounts duein 343 days
- Confirmation statement duein 313 days
- Accounts period endNet liabilities £35k · small accounts
- Accounts period endNet liabilities £35k · small accounts
- Accounts period endNet liabilities £33k · small accounts
- Incorporated
Similar companies in London
- STARK PHARMACEUTICALS LIMITEDLondon · inc. Aug 2020
- FENSTER CONSULTANTS LTDLondon · inc. Jul 2020
- MED X PHARMA TECH UK LIMITEDLondon · inc. Jul 2020
- CONSERV BIOSCIENCE LIMITEDLondon · inc. Oct 2020
- ORBYT GROUP LTDLondon · inc. May 2020
- MAITRI ARTHA SHASTRA LIMITEDLondon · inc. Nov 2020
All companies incorporated on 17 August 2020 · in Aug 2020.
Reminders for SPACEPHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.